De Anda JMC, Herrera GJC, Cárdenas AA, Morales ED, López GS, González-Chon O

Language: Spanish
References: 16
Page: 19-24
PDF size: 92.15 Kb.

ABSTRACT

Procalcitonin – a prohormone derived from Thyroid C cells – has been a useful marker in systemic inflammatory states, infectious and septic conditions during the last decade. There are several clinical studies that support its utility in such conditions, but when it comes to cardiac surgery only a scarce number of reports exist. The diagnosis of infection after cardiac surgery is not easy; there is lack of a 100% either sensitive or specific marker for such purposes. The surgical intervention herself produces a systemic inflammatory response syndrome and thus elevation of inflammation markers such as C reactive protein and procalctitonin in the absence of an infectious process. Elevated procalcitonin levels in the context of cardiac surgery nowadays should be translated with caution.

REFERENCES

1. Becker K, Snider R, Nylen E. Procalcitonin assay in systemic inflammation, infection and sepsis: Clinical utility and limitations. Crit Care Med 2008; 36-3: 941-952.

2. Remolina S. Procalcitonina; Marcador de inflamación sistémica. Médica Sur 2005; 12-4: 188-190.

3. Aouifi A, Piriou V, Bastein O, Balnc P et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000; 29-9: 3171-3177.

4. Lecharny JB, Khater D, Bronchard R. Hyperprocalcitonemia in patients with perioperative myocardial infraction after cardiac surgery. Crit Care Med 2001; 29-2: 323-325.

5. Jebali M, Hausfater P, Abbes Z, Aouni Z. Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery. Anesthesiology 2007; 107-2: 232-238.

6. Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery implications for the anesthesiologist. Anesthesiology 2002; 97: 215-52.

7. Amour J, Birembaum A, Langeron O et al. Influence of renal disfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008; 36-4: 1147-1154.

8. Sexton P, Christopoulos G, Christopoulos A, Nylen E. Procalcitonin has bioactivity at calcitonin receptor family complexes: Potential mediator implications in sepsis. Crit Care Med 2008; 36-5: 1637-1640.

9. Jensen J, Heslet L, Jensen T, Espersen K. Procalcitonin increase in early identification of critically ill patients al high risk of mortality. Crit Care Med 2006; 34-10: 2596-2602.

10. Dahaba A, Hagara B, Fall A, Rehak H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. British J of Anesthesia 2006; 97-4: 503-508.

11. Stolz D, Christ-Crain M, Bingisser R, Leuppi J. Antibiotic treatment of exacerbations of COPD. A randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007; 131-1: 9-19.

12. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohoun C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-518.

13. Al Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996; 1: 331-333.

14. de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25: 607-613.

15. Staehler M, Hammer C, Meiser B et al. Procalcitonin: A new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation. Transplant Proc 1997; 29: 584-585.

16. Hensel M, Volk T, Docke WD et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89: 93-104.